bluebirdbio
Robert Ross joins Surface Oncology as chief medical officer
December 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Surface Oncology, bluebirdbio
Surface Oncology, an immuno-oncology company developing immunotherapies that target the tumour microenvironment, has announced the appointment of Robert Ross as …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
